Researcher in lab

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 600 clinical trials open across 30 clinical units.

Find Melbourne Sexual Health Centre research studies and clinical trials
Clear filter
604 clinical trials found
Clinical trials

INFORMED-1

Integrative approaches for Optimizing Recognition, Management and Education of concussion at the community sports level (ACTRN12623000554662)

Currently recruiting

INI-822-001

A Phase 1 Randomised, Double-Blind, Placebo-Controlled, Single And Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of INI-822 In Healthy Volunteers And Participants With Non-Alcoholic Steatohepatitis [NASH] Or Presumed NASH (NCT05945537)

Currently recruiting

INSIGHT

An International, Phase 3, Randomized, Multicenter, Open label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated with Imatinib (INSIGHT) (NCT05734105)

Currently recruiting

INSPIRE

Invasive assessment of pulmonary microvascular function with novel indices of pulmonary flow reserve and pulmonary microcirculatory resistance. (Trial Not Registered)

Currently recruiting

Integrum

A multicentre, multinational, cohort long-term post-market Clinical [PMCF] follow-up of the safety and efficacy of the Osseo anchored Prostheses for the Rehabilitation of Amputees [OPRA] implant system when used for trans humeral implantation in amputee patients (NCT06753110)

Currently recruiting

INTENT

Intensive nutrition therapy compared to usual care in critically ill adults: A randomised pilot trial (NCT03292237)

Recently completed/closed

INTERCEPT-MGB453

AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial (ACTRN12621000439842)

Currently recruiting

INTERVENE

An ALLG Phase 2 study to Investigate Novel Triplets to Extend Remission with VENetoclax in Elderly (INTERVENE) Acute Myeloid Leukaemia (ACTRN12619001655134)

Currently recruiting

INVOKE-2

A phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of AL002 in participants with Early Alzheimer’s disease (NCT04592874)

No longer recruiting

IOS-1002

A Phase 1a/1b, first-in-human, open-label, non-randomized, multicenter, dose-escalation and cohort expansion study to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacokinetics, and pharmacodynamics of IOS-1002 administered alone and in combination with a PD-1 monoclonal antibody in advanced solid tumors (NCT05763004)

Currently recruiting

IRONMAN

International Registry for Men with Advanced Prostate Cancer (IRONMAN) (NCT03151629)

Currently recruiting

ISB1442-101

A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma(ACTRN12622000856718)

Currently recruiting

ITACS

IV iron for Treatment of Anaemia before Cardiac Surgery (NCT02632760)

Currently recruiting

IVIG Therapy in Lung Tx

A Randomised Double-blind Placebo-controlled Pilot Study of Intravenous Immunoglobulin Replacement Therapy in Lung Transplantation (ACTRN12618001394235)

No longer recruiting

IVY-P3-24-021

A Phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma (NCT06388733)

Currently recruiting

JADE

A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (NCT06256588)

Currently recruiting

KarMMa-9

A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel with Lenalidomide Maintenance Versus Lenalidomide Maintenance Therapy Alone in Adult Participants with Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9) (NCT06045806)

Currently recruiting

KER-012-A201

A Randomised, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hypertension (NCT05975905)

Currently recruiting

Keto eCoach

The Keto eCoach Program: a multimodality digital health intervention to aid the delivery of ketogenic diet therapy for epilepsy (ACTRN12624000486527)

Currently recruiting

KEYNOTE-630

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630) (NCT03833167)

No longer recruiting
15 16 17 18 19